 | • レポートコード：MRC2-11QY05697 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、153ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は子宮内膜症のグローバル市場について調査・分析したレポートです。種類別（ゴナドトロピン放出ホルモンアゴニスト、非ステロイド性抗炎症薬、プロゲスチン、経口避妊薬）市場規模、用途別（病院用、診療所用、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別子宮内膜症の競争状況、市場シェア ・世界の子宮内膜症市場：種類別市場規模 2015年-2020年（ゴナドトロピン放出ホルモンアゴニスト、非ステロイド性抗炎症薬、プロゲスチン、経口避妊薬） ・世界の子宮内膜症市場：種類別市場規模予測 2021年-2026年（ゴナドトロピン放出ホルモンアゴニスト、非ステロイド性抗炎症薬、プロゲスチン、経口避妊薬） ・世界の子宮内膜症市場：用途別市場規模 2015年-2020年（病院用、診療所用、その他） ・世界の子宮内膜症市場：用途別市場規模予測 2021年-2026年（病院用、診療所用、その他） ・北米の子宮内膜症市場分析：米国、カナダ ・ヨーロッパの子宮内膜症市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの子宮内膜症市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の子宮内膜症市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの子宮内膜症市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie、AstraZeneca、Bayer HealthCare、Pfizer、Addex Therapeutics、Astellas Pharma、Debiopharm、ElexoPharm、EndoCeutics、Euroscreen、Forendo Pharma、Kissei Pharmaceutical、Neurocrine Biosciences、Nippon Shinyaku、Takeda、Bayer AG、Neurocrine Biosciences ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Endometriosis is a medical condition in which the tissue that forms normal lining of uterus appears outside the uterus cavity and may involve ovaries, bowel or tissue lining of the pelvic floor.
Rising incidences of endometriosis due to diagnostic improvements leading to early identification, environmental factors, and rising awareness is the key factor contributing to growth of the market. Global endometriosis market is expected to register a healthy growth, owing to rise in awareness amongst patients and physicians. In addition, considerable research efforts towards development of novel non hormonal drugs, diagnostic and surgical techniques coupled with substantial support in terms of funding has helped to further enhance the growth of this market. Therefore, huge unmet needs for curative treatment of endometriosis will serve this market as a potential opportunity. The growth in global endometriosis market will be primarily driven by emerging Asian economies, where the disease prevalence is almost 10% of the total female population of this region.
Market Analysis and Insights: Global Endometriosis Market
The global Endometriosis market size is projected to reach US$ 1538.2 million by 2026, from US$ 1515.7 million in 2020, at a CAGR of 1.4%% during 2021-2026.
Global Endometriosis Scope and Market Size
Endometriosis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Endometriosis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Endometriosis market is segmented into
Gonadotropins Releasing Hormone Agonists
Non-Steroidal Anti-Inflammatory Drugs
Progestin
Oral Contraceptive Pills
Segment by Application, the Endometriosis market is segmented into
Hospital Use
Clinic Use
Other
Regional and Country-level Analysis
The Endometriosis market is analysed and market size information is provided by regions (countries).
The key regions covered in the Endometriosis market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Endometriosis Market Share Analysis
Endometriosis market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Endometriosis business, the date to enter into the Endometriosis market, Endometriosis product introduction, recent developments, etc.
The major vendors covered:
AbbVie
AstraZeneca
Bayer HealthCare
Pfizer
Addex Therapeutics
Astellas Pharma
Debiopharm
ElexoPharm
EndoCeutics
Euroscreen
Forendo Pharma
Kissei Pharmaceutical
Neurocrine Biosciences
Nippon Shinyaku
Takeda
Bayer AG
Neurocrine Biosciences
1 Study Coverage
1.1 Endometriosis Product Introduction
1.2 Market Segments
1.3 Key Endometriosis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Endometriosis Market Size Growth Rate by Type
1.4.2 Gonadotropins Releasing Hormone Agonists
1.4.3 Non-Steroidal Anti-Inflammatory Drugs
1.4.4 Progestin
1.4.5 Oral Contraceptive Pills
1.5 Market by Application
1.5.1 Global Endometriosis Market Size Growth Rate by Application
1.5.2 Hospital Use
1.5.3 Clinic Use
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Endometriosis Market Size, Estimates and Forecasts
2.1.1 Global Endometriosis Revenue 2015-2026
2.1.2 Global Endometriosis Sales 2015-2026
2.2 Global Endometriosis, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Endometriosis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Endometriosis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Endometriosis Competitor Landscape by Players
3.1 Endometriosis Sales by Manufacturers
3.1.1 Endometriosis Sales by Manufacturers (2015-2020)
3.1.2 Endometriosis Sales Market Share by Manufacturers (2015-2020)
3.2 Endometriosis Revenue by Manufacturers
3.2.1 Endometriosis Revenue by Manufacturers (2015-2020)
3.2.2 Endometriosis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Endometriosis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Endometriosis Revenue in 2019
3.2.5 Global Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Endometriosis Price by Manufacturers
3.4 Endometriosis Manufacturing Base Distribution, Product Types
3.4.1 Endometriosis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Endometriosis Product Type
3.4.3 Date of International Manufacturers Enter into Endometriosis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Endometriosis Market Size by Type (2015-2020)
4.1.1 Global Endometriosis Sales by Type (2015-2020)
4.1.2 Global Endometriosis Revenue by Type (2015-2020)
4.1.3 Endometriosis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Endometriosis Market Size Forecast by Type (2021-2026)
4.2.1 Global Endometriosis Sales Forecast by Type (2021-2026)
4.2.2 Global Endometriosis Revenue Forecast by Type (2021-2026)
4.2.3 Endometriosis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Endometriosis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Endometriosis Market Size by Application (2015-2020)
5.1.1 Global Endometriosis Sales by Application (2015-2020)
5.1.2 Global Endometriosis Revenue by Application (2015-2020)
5.1.3 Endometriosis Price by Application (2015-2020)
5.2 Endometriosis Market Size Forecast by Application (2021-2026)
5.2.1 Global Endometriosis Sales Forecast by Application (2021-2026)
5.2.2 Global Endometriosis Revenue Forecast by Application (2021-2026)
5.2.3 Global Endometriosis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Endometriosis by Country
6.1.1 North America Endometriosis Sales by Country
6.1.2 North America Endometriosis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Endometriosis Market Facts & Figures by Type
6.3 North America Endometriosis Market Facts & Figures by Application
7 Europe
7.1 Europe Endometriosis by Country
7.1.1 Europe Endometriosis Sales by Country
7.1.2 Europe Endometriosis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Endometriosis Market Facts & Figures by Type
7.3 Europe Endometriosis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Endometriosis by Region
8.1.1 Asia Pacific Endometriosis Sales by Region
8.1.2 Asia Pacific Endometriosis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Endometriosis Market Facts & Figures by Type
8.3 Asia Pacific Endometriosis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Endometriosis by Country
9.1.1 Latin America Endometriosis Sales by Country
9.1.2 Latin America Endometriosis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Endometriosis Market Facts & Figures by Type
9.3 Central & South America Endometriosis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Endometriosis by Country
10.1.1 Middle East and Africa Endometriosis Sales by Country
10.1.2 Middle East and Africa Endometriosis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Endometriosis Market Facts & Figures by Type
10.3 Middle East and Africa Endometriosis Market Facts & Figures by Application
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Endometriosis Products Offered
11.1.5 AbbVie Related Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description and Business Overview
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Endometriosis Products Offered
11.2.5 AstraZeneca Related Developments
11.3 Bayer HealthCare
11.3.1 Bayer HealthCare Corporation Information
11.3.2 Bayer HealthCare Description and Business Overview
11.3.3 Bayer HealthCare Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Bayer HealthCare Endometriosis Products Offered
11.3.5 Bayer HealthCare Related Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Description and Business Overview
11.4.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Pfizer Endometriosis Products Offered
11.4.5 Pfizer Related Developments
11.5 Addex Therapeutics
11.5.1 Addex Therapeutics Corporation Information
11.5.2 Addex Therapeutics Description and Business Overview
11.5.3 Addex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Addex Therapeutics Endometriosis Products Offered
11.5.5 Addex Therapeutics Related Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Corporation Information
11.6.2 Astellas Pharma Description and Business Overview
11.6.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Astellas Pharma Endometriosis Products Offered
11.6.5 Astellas Pharma Related Developments
11.7 Debiopharm
11.7.1 Debiopharm Corporation Information
11.7.2 Debiopharm Description and Business Overview
11.7.3 Debiopharm Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Debiopharm Endometriosis Products Offered
11.7.5 Debiopharm Related Developments
11.8 ElexoPharm
11.8.1 ElexoPharm Corporation Information
11.8.2 ElexoPharm Description and Business Overview
11.8.3 ElexoPharm Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ElexoPharm Endometriosis Products Offered
11.8.5 ElexoPharm Related Developments
11.9 EndoCeutics
11.9.1 EndoCeutics Corporation Information
11.9.2 EndoCeutics Description and Business Overview
11.9.3 EndoCeutics Sales, Revenue and Gross Margin (2015-2020)
11.9.4 EndoCeutics Endometriosis Products Offered
11.9.5 EndoCeutics Related Developments
11.10 Euroscreen
11.10.1 Euroscreen Corporation Information
11.10.2 Euroscreen Description and Business Overview
11.10.3 Euroscreen Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Euroscreen Endometriosis Products Offered
11.10.5 Euroscreen Related Developments
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Description and Business Overview
11.1.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AbbVie Endometriosis Products Offered
11.1.5 AbbVie Related Developments
11.12 Kissei Pharmaceutical
11.12.1 Kissei Pharmaceutical Corporation Information
11.12.2 Kissei Pharmaceutical Description and Business Overview
11.12.3 Kissei Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Kissei Pharmaceutical Products Offered
11.12.5 Kissei Pharmaceutical Related Developments
11.13 Neurocrine Biosciences
11.13.1 Neurocrine Biosciences Corporation Information
11.13.2 Neurocrine Biosciences Description and Business Overview
11.13.3 Neurocrine Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Neurocrine Biosciences Products Offered
11.13.5 Neurocrine Biosciences Related Developments
11.14 Nippon Shinyaku
11.14.1 Nippon Shinyaku Corporation Information
11.14.2 Nippon Shinyaku Description and Business Overview
11.14.3 Nippon Shinyaku Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Nippon Shinyaku Products Offered
11.14.5 Nippon Shinyaku Related Developments
11.15 Takeda
11.15.1 Takeda Corporation Information
11.15.2 Takeda Description and Business Overview
11.15.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Takeda Products Offered
11.15.5 Takeda Related Developments
11.16 Bayer AG
11.16.1 Bayer AG Corporation Information
11.16.2 Bayer AG Description and Business Overview
11.16.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Bayer AG Products Offered
11.16.5 Bayer AG Related Developments
11.17 Neurocrine Biosciences
11.17.1 Neurocrine Biosciences Corporation Information
11.17.2 Neurocrine Biosciences Description and Business Overview
11.17.3 Neurocrine Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Neurocrine Biosciences Products Offered
11.17.5 Neurocrine Biosciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Endometriosis Market Estimates and Projections by Region
12.1.1 Global Endometriosis Sales Forecast by Regions 2021-2026
12.1.2 Global Endometriosis Revenue Forecast by Regions 2021-2026
12.2 North America Endometriosis Market Size Forecast (2021-2026)
12.2.1 North America: Endometriosis Sales Forecast (2021-2026)
12.2.2 North America: Endometriosis Revenue Forecast (2021-2026)
12.2.3 North America: Endometriosis Market Size Forecast by Country (2021-2026)
12.3 Europe Endometriosis Market Size Forecast (2021-2026)
12.3.1 Europe: Endometriosis Sales Forecast (2021-2026)
12.3.2 Europe: Endometriosis Revenue Forecast (2021-2026)
12.3.3 Europe: Endometriosis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Endometriosis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Endometriosis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Endometriosis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Endometriosis Market Size Forecast by Region (2021-2026)
12.5 Latin America Endometriosis Market Size Forecast (2021-2026)
12.5.1 Latin America: Endometriosis Sales Forecast (2021-2026)
12.5.2 Latin America: Endometriosis Revenue Forecast (2021-2026)
12.5.3 Latin America: Endometriosis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Endometriosis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Endometriosis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Endometriosis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Endometriosis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Endometriosis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Endometriosis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Endometriosis Market Segments
Table 2. Ranking of Global Top Endometriosis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Endometriosis Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Gonadotropins Releasing Hormone Agonists
Table 5. Major Manufacturers of Non-Steroidal Anti-Inflammatory Drugs
Table 6. Major Manufacturers of Progestin
Table 7. Major Manufacturers of Oral Contraceptive Pills
Table 8. Global Endometriosis Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global Endometriosis Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global Endometriosis Sales by Regions 2015-2020 (K Units)
Table 11. Global Endometriosis Sales Market Share by Regions (2015-2020)
Table 12. Global Endometriosis Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Endometriosis Sales by Manufacturers (2015-2020) (K Units)
Table 14. Global Endometriosis Sales Share by Manufacturers (2015-2020)
Table 15. Global Endometriosis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Endometriosis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis as of 2019)
Table 17. Endometriosis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Endometriosis Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Endometriosis Price (2015-2020) (USD/Unit)
Table 20. Endometriosis Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Endometriosis Product Type
Table 22. Date of International Manufacturers Enter into Endometriosis Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Endometriosis Sales by Type (2015-2020) (K Units)
Table 25. Global Endometriosis Sales Share by Type (2015-2020)
Table 26. Global Endometriosis Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Endometriosis Revenue Share by Type (2015-2020)
Table 28. Endometriosis Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 29. Global Endometriosis Sales by Application (2015-2020) (K Units)
Table 30. Global Endometriosis Sales Share by Application (2015-2020)
Table 31. North America Endometriosis Sales by Country (2015-2020) (K Units)
Table 32. North America Endometriosis Sales Market Share by Country (2015-2020)
Table 33. North America Endometriosis Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Endometriosis Revenue Market Share by Country (2015-2020)
Table 35. North America Endometriosis Sales by Type (2015-2020) (K Units)
Table 36. North America Endometriosis Sales Market Share by Type (2015-2020)
Table 37. North America Endometriosis Sales by Application (2015-2020) (K Units)
Table 38. North America Endometriosis Sales Market Share by Application (2015-2020)
Table 39. Europe Endometriosis Sales by Country (2015-2020) (K Units)
Table 40. Europe Endometriosis Sales Market Share by Country (2015-2020)
Table 41. Europe Endometriosis Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Endometriosis Revenue Market Share by Country (2015-2020)
Table 43. Europe Endometriosis Sales by Type (2015-2020) (K Units)
Table 44. Europe Endometriosis Sales Market Share by Type (2015-2020)
Table 45. Europe Endometriosis Sales by Application (2015-2020) (K Units)
Table 46. Europe Endometriosis Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Endometriosis Sales by Region (2015-2020) (K Units)
Table 48. Asia Pacific Endometriosis Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Endometriosis Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Endometriosis Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Endometriosis Sales by Type (2015-2020) (K Units)
Table 52. Asia Pacific Endometriosis Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Endometriosis Sales by Application (2015-2020) (K Units)
Table 54. Asia Pacific Endometriosis Sales Market Share by Application (2015-2020)
Table 55. Latin America Endometriosis Sales by Country (2015-2020) (K Units)
Table 56. Latin America Endometriosis Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Endometriosis Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Endometriosis Revenue Market Share by Country (2015-2020)
Table 59. Latin America Endometriosis Sales by Type (2015-2020) (K Units)
Table 60. Latin America Endometriosis Sales Market Share by Type (2015-2020)
Table 61. Latin America Endometriosis Sales by Application (2015-2020) (K Units)
Table 62. Latin America Endometriosis Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Endometriosis Sales by Country (2015-2020) (K Units)
Table 64. Middle East and Africa Endometriosis Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Endometriosis Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Endometriosis Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Endometriosis Sales by Type (2015-2020) (K Units)
Table 68. Middle East and Africa Endometriosis Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Endometriosis Sales by Application (2015-2020) (K Units)
Table 70. Middle East and Africa Endometriosis Sales Market Share by Application (2015-2020)
Table 71. AbbVie Corporation Information
Table 72. AbbVie Description and Major Businesses
Table 73. AbbVie Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. AbbVie Product
Table 75. AbbVie Recent Development
Table 76. AstraZeneca Corporation Information
Table 77. AstraZeneca Description and Major Businesses
Table 78. AstraZeneca Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. AstraZeneca Product
Table 80. AstraZeneca Recent Development
Table 81. Bayer HealthCare Corporation Information
Table 82. Bayer HealthCare Description and Major Businesses
Table 83. Bayer HealthCare Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Bayer HealthCare Product
Table 85. Bayer HealthCare Recent Development
Table 86. Pfizer Corporation Information
Table 87. Pfizer Description and Major Businesses
Table 88. Pfizer Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Pfizer Product
Table 90. Pfizer Recent Development
Table 91. Addex Therapeutics Corporation Information
Table 92. Addex Therapeutics Description and Major Businesses
Table 93. Addex Therapeutics Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Addex Therapeutics Product
Table 95. Addex Therapeutics Recent Development
Table 96. Astellas Pharma Corporation Information
Table 97. Astellas Pharma Description and Major Businesses
Table 98. Astellas Pharma Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Astellas Pharma Product
Table 100. Astellas Pharma Recent Development
Table 101. Debiopharm Corporation Information
Table 102. Debiopharm Description and Major Businesses
Table 103. Debiopharm Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Debiopharm Product
Table 105. Debiopharm Recent Development
Table 106. ElexoPharm Corporation Information
Table 107. ElexoPharm Description and Major Businesses
Table 108. ElexoPharm Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. ElexoPharm Product
Table 110. ElexoPharm Recent Development
Table 111. EndoCeutics Corporation Information
Table 112. EndoCeutics Description and Major Businesses
Table 113. EndoCeutics Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. EndoCeutics Product
Table 115. EndoCeutics Recent Development
Table 116. Euroscreen Corporation Information
Table 117. Euroscreen Description and Major Businesses
Table 118. Euroscreen Endometriosis Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. Euroscreen Product
Table 120. Euroscreen Recent Development
Table 121. Forendo Pharma Corporation Information
Table 122. Forendo Pharma Description and Major Businesses
Table 123. Forendo Pharma Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Forendo Pharma Product
Table 125. Forendo Pharma Recent Development
Table 126. Kissei Pharmaceutical Corporation Information
Table 127. Kissei Pharmaceutical Description and Major Businesses
Table 128. Kissei Pharmaceutical Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. Kissei Pharmaceutical Product
Table 130. Kissei Pharmaceutical Recent Development
Table 131. Neurocrine Biosciences Corporation Information
Table 132. Neurocrine Biosciences Description and Major Businesses
Table 133. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Neurocrine Biosciences Product
Table 135. Neurocrine Biosciences Recent Development
Table 136. Nippon Shinyaku Corporation Information
Table 137. Nippon Shinyaku Description and Major Businesses
Table 138. Nippon Shinyaku Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 139. Nippon Shinyaku Product
Table 140. Nippon Shinyaku Recent Development
Table 141. Takeda Corporation Information
Table 142. Takeda Description and Major Businesses
Table 143. Takeda Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 144. Takeda Product
Table 145. Takeda Recent Development
Table 146. Bayer AG Corporation Information
Table 147. Bayer AG Description and Major Businesses
Table 148. Bayer AG Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 149. Bayer AG Product
Table 150. Bayer AG Recent Development
Table 151. Neurocrine Biosciences Corporation Information
Table 152. Neurocrine Biosciences Description and Major Businesses
Table 153. Neurocrine Biosciences Endometriosis Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. Neurocrine Biosciences Product
Table 155. Neurocrine Biosciences Recent Development
Table 156. Global Endometriosis Sales Forecast by Regions (2021-2026) (K Units)
Table 157. Global Endometriosis Sales Market Share Forecast by Regions (2021-2026)
Table 158. Global Endometriosis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 159. Global Endometriosis Revenue Market Share Forecast by Regions (2021-2026)
Table 160. North America: Endometriosis Sales Forecast by Country (2021-2026) (K Units)
Table 161. North America: Endometriosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Europe: Endometriosis Sales Forecast by Country (2021-2026) (K Units)
Table 163. Europe: Endometriosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Asia Pacific: Endometriosis Sales Forecast by Region (2021-2026) (K Units)
Table 165. Asia Pacific: Endometriosis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 166. Latin America: Endometriosis Sales Forecast by Country (2021-2026) (K Units)
Table 167. Latin America: Endometriosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 168. Middle East and Africa: Endometriosis Sales Forecast by Country (2021-2026) (K Units)
Table 169. Middle East and Africa: Endometriosis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 170. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 171. Key Challenges
Table 172. Market Risks
Table 173. Main Points Interviewed from Key Endometriosis Players
Table 174. Endometriosis Customers List
Table 175. Endometriosis Distributors List
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Endometriosis Product Picture
Figure 2. Global Endometriosis Sales Market Share by Type in 2020 & 2026
Figure 3. Gonadotropins Releasing Hormone Agonists Product Picture
Figure 4. Non-Steroidal Anti-Inflammatory Drugs Product Picture
Figure 5. Progestin Product Picture
Figure 6. Oral Contraceptive Pills Product Picture
Figure 7. Global Endometriosis Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital Use
Figure 9. Clinic Use
Figure 10. Other
Figure 11. Endometriosis Report Years Considered
Figure 12. Global Endometriosis Market Size 2015-2026 (US$ Million)
Figure 13. Global Endometriosis Sales 2015-2026 (K Units)
Figure 14. Global Endometriosis Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Endometriosis Sales Market Share by Region (2015-2020)
Figure 16. Global Endometriosis Sales Market Share by Region in 2019
Figure 17. Global Endometriosis Revenue Market Share by Region (2015-2020)
Figure 18. Global Endometriosis Revenue Market Share by Region in 2019
Figure 19. Global Endometriosis Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Endometriosis Revenue in 2019
Figure 21. Endometriosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Endometriosis Sales Market Share by Type (2015-2020)
Figure 23. Global Endometriosis Sales Market Share by Type in 2019
Figure 24. Global Endometriosis Revenue Market Share by Type (2015-2020)
Figure 25. Global Endometriosis Revenue Market Share by Type in 2019
Figure 26. Global Endometriosis Market Share by Price Range (2015-2020)
Figure 27. Global Endometriosis Sales Market Share by Application (2015-2020)
Figure 28. Global Endometriosis Sales Market Share by Application in 2019
Figure 29. Global Endometriosis Revenue Market Share by Application (2015-2020)
Figure 30. Global Endometriosis Revenue Market Share by Application in 2019
Figure 31. North America Endometriosis Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Endometriosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Endometriosis Sales Market Share by Country in 2019
Figure 34. North America Endometriosis Revenue Market Share by Country in 2019
Figure 35. U.S. Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Endometriosis Market Share by Type in 2019
Figure 40. North America Endometriosis Market Share by Application in 2019
Figure 41. Europe Endometriosis Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Endometriosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Endometriosis Sales Market Share by Country in 2019
Figure 44. Europe Endometriosis Revenue Market Share by Country in 2019
Figure 45. Germany Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Endometriosis Market Share by Type in 2019
Figure 56. Europe Endometriosis Market Share by Application in 2019
Figure 57. Asia Pacific Endometriosis Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Endometriosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Endometriosis Sales Market Share by Region in 2019
Figure 60. Asia Pacific Endometriosis Revenue Market Share by Region in 2019
Figure 61. China Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Endometriosis Market Share by Type in 2019
Figure 84. Asia Pacific Endometriosis Market Share by Application in 2019
Figure 85. Latin America Endometriosis Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Endometriosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Endometriosis Sales Market Share by Country in 2019
Figure 88. Latin America Endometriosis Revenue Market Share by Country in 2019
Figure 89. Mexico Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Endometriosis Market Share by Type in 2019
Figure 96. Latin America Endometriosis Market Share by Application in 2019
Figure 97. Middle East and Africa Endometriosis Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Endometriosis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Endometriosis Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Endometriosis Revenue Market Share by Country in 2019
Figure 101. Turkey Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Endometriosis Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Endometriosis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Endometriosis Market Share by Type in 2019
Figure 108. Middle East and Africa Endometriosis Market Share by Application in 2019
Figure 109. North America Endometriosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Endometriosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Endometriosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Endometriosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Endometriosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Endometriosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Endometriosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Endometriosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Endometriosis Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Endometriosis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
子宮内膜症治療薬の世界市場（～2026年） Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years. Among these therapies, Elagolix, a first-in-class GnRH receptor antagonist, is closest to market. Market Analysis and Insights: Global Endometriosis Drugs Market The global Endometriosis Drugs market size …- 非ステロイド性抗炎症薬（NSAID）の世界市場（～2026年） Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
- 抗炎症薬の世界市場（～2026年） Market Analysis and Insights: Global Anti-inflammatory Drugs Market The global Anti-inflammatory Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Anti-inflammatory Drugs Scope and Market Size Anti-inflammatory Dru…
- 避妊薬の世界市場（～2026年） Contraceptive Drugs are medications that prevent pregnancy. They are one method of birth control Birth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocki…
- 避妊薬・避妊具の世界市場（～2026年） A contraceptive is a device or drug that prevents a woman from becoming pregnant. The key factors contributing to the contraceptive drugs and devices market are growing prevalence of sexually transmitted diseases and the growing need to control the rising population. Market Analysis and Insights: Gl…